Prognostic value of risk stratification using blood biochemical parameters in Japanese patients with metastatic renal cell carcinoma treated by nivolumab

被引：0
|
作者：
Yamamoto, Yoshiaki
Matsuyama, Hideyasu
Matsumoto, Hiroaki
Sakano, Shigeru
Fujii, Nakanori
Oba, Kazuo
Yamamoto, Mitsutaka
Kamiryo, Yoriaki
Hiragino, Takeshi
Nagao, Kazuhiro
Takai, Kimio
Aoki, Akihiko
Yoshihiro, Satoru
Tsukamoto, Manabu
Akao, Jumpei
Kitahara, Seiji
Misumi, Taku
Komatsu, Hirotaka
Oka, Shintaro
Suga, Akinobu
机构：
[1] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi, Japan
[2] Yamaguchi Univ, Ube, Yamaguchi, Japan
[3] Kokura Mem Hosp, Dept Urol, Kitakyushu, Japan
[4] Tokuyama Cent Hosp, Dept Urol & Nephrol, Shunan, Japan
[5] Saiseikai Yamaguchi Gen Hosp, Dept Urol, Yamaguchi, Japan
[6] Yamaguchi Grand Med Ctr, Dept Urol, Hofu, Japan
[7] Shimonoseki Saisekai Toyoura Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[8] Nagato Gen Hosp, Dept Urol, Nagato, Japan
[9] Shuto Gen Hosp, Yanai, Japan
[10] Saiseikai Shimonoseki Gen Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[11] Masuda Red Cross Hosp, Dept Urol, Masuda, Japan
[12] Shimonoseki City Hosp, Dept Urol, Shimonoseki, Yamaguchi, Japan
[13] Yamaguchi Red Cross Hosp, Dept Urol, Yamaguchi, Japan
[14] Ogori Daiichi Gen Hosp, Yamaguchi, Japan
[15] Sanyo Onoda Municipal Hosp, Sanyo Onoda, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
724
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prognostic value of risk stratification using blood parameters for nivolumab in Japanese patients with metastatic renal-cell carcinoma
    Yamamoto, Yoshiaki
    Matsuyama, Hideyasu
    Matsumoto, Hiroaki
    Sakano, Shigeru
    Fuji, Nakanori
    Oba, Kazuo
    Yamamoto, Mitsutaka
    Kamiryo, Yoriaki
    Hiragino, Takeshi
    Nagao, Kazuhiro
    Takai, Kimio
    Aoki, Akihiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (02) : 214 - 220
  • [2] The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
    Yoshimura, Akihiro
    Nagahara, Akira
    Ishizuya, Yu
    Yamamoto, Yoshiyuki
    Hatano, Koji
    Kawashima, Atsunari
    Nakai, Yasutomo
    Nakayama, Masashi
    Nishimura, Kazuo
    Nonomura, Norio
    Kato, Taigo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [3] Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
    Wakita, Naoto
    Hinata, Nobuyuki
    Bando, Yukari
    Hara, Takuto
    Terakawa, Tomoaki
    Furukawa, Junya
    Nakano, Yuzo
    Fujisawa, Masato
    ANTICANCER RESEARCH, 2023, 43 (02) : 841 - 847
  • [4] Prognostic Value of Hemoglobin, Albumin, Lymphocyte, Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab
    Tomcova, Zuzana
    Obertova, Jana
    Chovanec, Michal
    Sycova-Mila, Zuzana
    Stefanikova, Katarina
    Slachtova, Eva
    Zak, Monika
    Savka, Alexander
    Hrncar, Matej
    Rejlekova, Katarina
    Palacka, Patrik
    BIOMEDICINES, 2025, 13 (02)
  • [5] Inflammatory Prognostic Index in Metastatic Renal Carcinoma Treated with Nivolumab
    Ekinci, Ferhat
    Erdogan, Atike Pinar
    Yildirim, Serkan
    Bulut, Gulcan
    Yilmaz, Cengiz
    Barutca, Sabri
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (10): : 1288 - 1294
  • [6] Prognostic Value of Hematologic Parameters in Patients with Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors
    Gunduz, Seyda
    Mutlu, Hasan
    Uysal, Mukremin
    Coskun, Hasan Senol
    Bozcuk, Hakan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (08) : 3801 - 3804
  • [7] Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab
    Damassi, Alessandra
    Cremante, Malvina
    Signori, Alessio
    Rebuzzi, Sara Elena
    Malgeri, Andrea
    Napoli, Marilena Di
    Caffo, Orazio
    Vignani, Francesca
    Cavo, Alessia
    Roviello, Giandomenico
    Prati, Veronica
    Tudini, Marianna
    Atzori, Francesco
    Messina, Marco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Catalano, Fabio
    Murianni, Veronica
    Rescigno, Pasquale
    Banna, Giuseppe Luigi
    Fornarini, Giuseppe
    Buti, Sebastiano
    IMMUNOTHERAPY, 2024, 16 (18-19) : 1095 - 1103
  • [8] Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab
    Damassi, Alessandra
    Cremante, Malvina
    Signori, Alessio
    Rebuzzi, Sara Elena
    Malgeri, Andrea
    Napoli, Marilena Di
    Caffo, Orazio
    Vignani, Francesca
    Cavo, Alessia
    Roviello, Giandomenico
    Prati, Veronica
    Tudini, Marianna
    Atzori, Francesco
    Messina, Marco
    Morelli, Franco
    Prati, Giuseppe
    Nole, Franco
    Catalano, Fabio
    Murianni, Veronica
    Rescigno, Pasquale
    Banna, Giuseppe Luigi
    Fornarini, Giuseppe
    Buti, Sebastiano
    IMMUNOTHERAPY, 2024,
  • [9] A comprehensive prognostic stratification for patients with metastatic renal clear cell carcinoma
    Cho, Kang Su
    Choi, Young Deuk
    Kim, Se Joong
    Kim, Chun Il
    Chung, Byung Ha
    Seong, Do Hwan
    Lee, Dong Hyeon
    Cho, Jin Seon
    Cho, In Rae
    Hong, Sung Joon
    YONSEI MEDICAL JOURNAL, 2008, 49 (03) : 451 - 458
  • [10] Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 539 - 546
12345